The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Right arrow Help viewing high resolution images
Right arrow Return to article

 

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

 

Click on image to view larger version.



Figure 1. Bim is required for BCR ligation–induced killing of immature and mature B lymphocytes. (A) Immature B cells sorted from spleen as B220+IgM+IgD- were cultured overnight in the presence of F(ab')2 anti-IgM antibodies and then assessed for viability. Cell survival after 15 h BCR ligation was calculated as a percentage of B cell survival in unstimulated cultures. B cells show a dose-dependent killing reaching 60% at 50 µg/mL for controls, 30% for bim-/-, and <10% for bcl-2 transgene-expressing cells. (B) Same as for A, except mature B cells were negatively sorted from LNs as Thy1-Mac-1-Gr-1-Ter119- cells. Control B cells show 50% death at 50 µg/mL F(ab')2 anti-IgM antibodies, whereas bim-/- and bcl-2 transgenic B cells show 15 and 5%, respectively. (C) Same as for B, except B cells were stimulated with plate-bound F(ab')2 anti-IgM antibodies, inducing more severe cell death as evidenced by the 80% cell death of control B cells, 40% death of bim-/- B cells, and 20% death of bcl-2 transgene-expressing B cells at 50 µg/mL anti-IgM antibody concentration.





Right arrow Return to article


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS